MoonLake Immunotherapeutics (MLTX)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20260 patents granted to the name below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to MoonLake Immunotherapeutics’s names, not what it holds today.
4 published
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Oct 16, 2025 | 2025/0321236 | BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS | Pharmaceuticals | MOONLAKE IMMUNOTHERAPEUTICS AG |
| Aug 7, 2025 | 2025/0251406 | BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS | Pharmaceuticals | MOONLAKE IMMUNOTHERAPEUTICS AG |
| Aug 7, 2025 | 2025/0250332 | BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS | Pharmaceuticals | MOONLAKE IMMUNOTHERAPEUTICS AG |
| Feb 6, 2025 | 2025/0042988 | METHODS OF ACHIEVING SAFE AND SUSTAINED CONTROL OF IL-17-DEPENDENT CONDITIONS IN SUBJECTS RESPONSIVE TO TREATMENT WITH AN ANTI-IL 17A/F NANOBODY | Pharmaceuticals | MOONLAKE IMMUNOTHERAPEUTICS AG |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.